Biomaterial Database

Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients. 1996

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Temple University Schools of Pharmacy and Medicine Philadelphia, Pennsylvania 19140, USA.

UI	MeSH Term	Description	Entries
D007166	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.	Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007262	Infusions, Intravenous	The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.	Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008657	Metabolic Clearance Rate	Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.	Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D004304	Dosage Forms	Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect.	Dosage Form,Form, Dosage,Forms, Dosage
D004655	Emulsions	Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.	Emulsion
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284	Administration, Oral	The giving of drugs, chemicals, or other substances by mouth.	Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001682	Biological Availability	The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.	Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D016031	Liver Transplantation	The transference of a part of or an entire liver from one human or animal to another.	Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.

June 1998, Transplantation proceedings,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.

June 1997, Transplantation,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.

December 1995, Transplantation,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Improved cyclosporine bioavailability in black pediatric liver transplant recipients after administration of the microemulsion formulation.

March 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Circadian variations in the pharmacokinetics of a new microemulsion formulation of cyclosporine in cardiac transplant recipients.

January 1998, Pharmacotherapy,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.

June 1995, Therapeutic drug monitoring,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Cyclosporine pharmacokinetics in pediatric transplant recipients.

September 1989, Therapeutic drug monitoring,

G F Cooney, and B L Lum, and J A Meligeni, and S P Dunn

Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.

August 1998, Transplantation proceedings,